Delaware General Assembly

Signed 1/25/12

The General Assembly has ended, the current status is the final status.

1/7/12

Hall-Long

Sen. DeLuca, Blevins, Bushweller, Cloutier
Reps. Walker, Mulrooney, Mitchell, B. Bennett, Scott

Sen. Henry, Sokola, Peterson, Bunting, Connor, Ennis, Venables, Booth, Lawson, F Simpson, Sorenson
Reps. Gilligan, Schwartzkopf, Keeley, Lavelle, Hocker, Kowalko, Osienski, Q. Johnson, Heffernan, Hudson, Miro, Atkins, Barbieri, Viola, Jaques, Schooley, Kenton, Outten, Wilson, Lee, M. Smith, Carson, Ramone, Peterman, Blakey, D. Short, Willis

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.

This Act amends the Uniformed Controlled Substances Act by clarifying that the definition of “designer drugs” covers those synthetic analogues of controlled substances that are made and distributed for drug use but due to their novelty have not yet been added to the schedule of controlled substances. This amendment to Delaware’s drug code will ensure there are no gaps in the law’s coverage of these dangerous substances as they surface. One such recent example is “bath salts.” This Act bans the possession, use, sale, or delivery of synthetic cathinones, more commonly known as “bath salts,” by categorizing synthetic cathinones as a Schedule I controlled substance under 16 Del. C. §4714(f). This Act also removes “synthetic cannabanoids” from the definition section of the Uniform Controlled Substances Act and categorizes the chemical compounds within the Schedule I controlled substance under 16 Del. C. § 4714(d). Finally, this Act creates Tier Quantities for Schedule I controlled substances, such as “bath salts,” not otherwise included in 16 Del. C. § 4751C.

N/A

N/A

Takes effect upon being signed into law

N/A

View HTML View PDF